231 related articles for article (PubMed ID: 23102701)
1. Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes.
Singer S; Zhao R; Barsotti AM; Ouwehand A; Fazollahi M; Coutavas E; Breuhahn K; Neumann O; Longerich T; Pusterla T; Powers MA; Giles KM; Leedman PJ; Hess J; Grunwald D; Bussemaker HJ; Singer RH; Schirmacher P; Prives C
Mol Cell; 2012 Dec; 48(5):799-810. PubMed ID: 23102701
[TBL] [Abstract][Full Text] [Related]
2. Nucleoporin Nup155 is part of the p53 network in liver cancer.
Holzer K; Ori A; Cooke A; Dauch D; Drucker E; Riemenschneider P; Andres-Pons A; DiGuilio AL; Mackmull MT; Baßler J; Roessler S; Breuhahn K; Zender L; Glavy JS; Dombrowski F; Hurt E; Schirmacher P; Beck M; Singer S
Nat Commun; 2019 May; 10(1):2147. PubMed ID: 31089132
[TBL] [Abstract][Full Text] [Related]
3. Tumor-suppressor effect of interferon regulatory factor-1 in human hepatocellular carcinoma.
Moriyama Y; Nishiguchi S; Tamori A; Koh N; Yano Y; Kubo S; Hirohashi K; Otani S
Clin Cancer Res; 2001 May; 7(5):1293-8. PubMed ID: 11350897
[TBL] [Abstract][Full Text] [Related]
4. The centrosomal protein Tax1 binding protein 2 is a novel tumor suppressor in hepatocellular carcinoma regulated by cyclin-dependent kinase 2.
Lai WL; Hung WY; Wong LL; Zhou Y; Leong VY; Lee JM; Ng IO; Jin DY; Ching YP
Hepatology; 2012 Nov; 56(5):1770-81. PubMed ID: 22610972
[TBL] [Abstract][Full Text] [Related]
5. TSG101 promotes the proliferation, migration and invasion of hepatocellular carcinoma cells by regulating the PEG10.
Liu Z; Tian Z; Cao K; Zhang B; Wen Q; Zhou X; Yang W; Wang T; Shi H; Wang R
J Cell Mol Med; 2019 Jan; 23(1):70-82. PubMed ID: 30450735
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of c-FLIP expression by miR-512-3p contributes to taxol-induced apoptosis in hepatocellular carcinoma cells.
Chen F; Zhu HH; Zhou LF; Wu SS; Wang J; Chen Z
Oncol Rep; 2010 May; 23(5):1457-62. PubMed ID: 20372864
[TBL] [Abstract][Full Text] [Related]
7. Variant 1 of KIAA0101, overexpressed in hepatocellular carcinoma, prevents doxorubicin-induced apoptosis by inhibiting p53 activation.
Liu L; Chen X; Xie S; Zhang C; Qiu Z; Zhu F
Hepatology; 2012 Nov; 56(5):1760-9. PubMed ID: 22576474
[TBL] [Abstract][Full Text] [Related]
8. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
9. circLARP4 induces cellular senescence through regulating miR-761/RUNX3/p53/p21 signaling in hepatocellular carcinoma.
Chen Z; Zuo X; Pu L; Zhang Y; Han G; Zhang L; Wu J; Wang X
Cancer Sci; 2019 Feb; 110(2):568-581. PubMed ID: 30520539
[TBL] [Abstract][Full Text] [Related]
10. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
Fornari F; Milazzo M; Chieco P; Negrini M; Marasco E; Capranico G; Mantovani V; Marinello J; Sabbioni S; Callegari E; Cescon M; Ravaioli M; Croce CM; Bolondi L; Gramantieri L
J Pathol; 2012 Jul; 227(3):275-85. PubMed ID: 22262409
[TBL] [Abstract][Full Text] [Related]
11. Upregulated TRIM11 Exerts its Oncogenic Effects in Hepatocellular Carcinoma Through Inhibition of P53.
Liu J; Rao J; Lou X; Zhai J; Ni Z; Wang X
Cell Physiol Biochem; 2017; 44(1):255-266. PubMed ID: 29190611
[TBL] [Abstract][Full Text] [Related]
12. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Dai QS; Liu W; Wang XB; Lu N; Gong DD; Kong LY; Guo QL
Anticancer Drugs; 2011 Jan; 22(1):46-57. PubMed ID: 20948430
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53.
Chen L; Luo L; Chen W; Xu HX; Chen F; Chen LZ; Zeng WT; Chen JS; Huang XH
Biomed Pharmacother; 2016 Dec; 84():1113-1118. PubMed ID: 27780140
[TBL] [Abstract][Full Text] [Related]
14. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis.
Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL
J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944
[TBL] [Abstract][Full Text] [Related]
15. The cyclin-dependent kinase inhibitor p21 is regulated by RNA-binding protein PCBP4 via mRNA stability.
Scoumanne A; Cho SJ; Zhang J; Chen X
Nucleic Acids Res; 2011 Jan; 39(1):213-24. PubMed ID: 20817677
[TBL] [Abstract][Full Text] [Related]
16. Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21(CIP1/WAF1) in the liver.
Yeganeh M; Gui Y; Kandhi R; Bobbala D; Tobelaim WS; Saucier C; Yoshimura A; Ferbeyre G; Ramanathan S; Ilangumaran S
Oncogene; 2016 Aug; 35(32):4200-11. PubMed ID: 26725321
[TBL] [Abstract][Full Text] [Related]
17. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
[TBL] [Abstract][Full Text] [Related]
18. Copper alters the conformation and transcriptional activity of the tumor suppressor protein p53 in human Hep G2 cells.
Tassabehji NM; VanLandingham JW; Levenson CW
Exp Biol Med (Maywood); 2005 Nov; 230(10):699-708. PubMed ID: 16246896
[TBL] [Abstract][Full Text] [Related]
19. The homeobox transcription factor Prox1 inhibits proliferation of hepatocellular carcinoma cells by inducing p53-dependent senescence-like phenotype.
Chang TM; Hung WC
Cancer Biol Ther; 2013 Mar; 14(3):222-9. PubMed ID: 23291986
[TBL] [Abstract][Full Text] [Related]
20. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
